stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Burning Rock Biotech Ltd AdrBNR
$13.250.30%-0.04

Burning Rock Biotech Ltd Adr (BNR)

Burning Rock Biotech Ltd Adr stock is traded at $13.25, with a volume of 150. It is down -0.30% in the last 24 hours and up +2.71% over the past month. Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
Previous Close:
$13.29
Open:
$13.25
24h Volume:
150
Relative Volume:
0.01
Market Cap:
$139.74M
Revenue:
$72.33M
Net Income/Loss:
-$8.38M
P/E Ratio:
-
EPS:
-$0.7881
Net Cash Flow:
-$4.95M
1W Performance:
+6.94%
1M Performance:
+2.71%
6M Performance:
-22.24%
1Y Performance:
+12.86%
1-Day Range:
$13.25$13.25
1-Week Range:
$12.30$13.60
52-Week Range:
$6.79$41.72

Burning Rock Biotech Ltd Adr Stock (BNR) Company Profile

Name
Burning Rock Biotech Ltd Adr
Phone
-
Address
China
Employee
667
X
-
Next Earnings Date
2026-11-19
Latest SEC Filings
SEC
BNR's Discussions on X
X

 

Market Cap

 

Revenue

 

Net Income

 

Cash Flow

 

EPS

 

Burning Rock Biotech Ltd Adr Stock (BNR) Financials Data

Similar to BNR